Biosyngen Pte. Ltd. is the Global Leader in Cell and Gene Therapy and was established in Singapore on 1 July 2016 as an immuno-oncology company. It collaborates with leading biomedical research and clinical institutes in Germany, Australia, China, and Singapore. BioSyngen is utilizing our proprietary technology platforms to develop next-generation CAR-T and TCR-T therapies to target unmet medical needs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.